Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone marrow examination in small cell lung cancer--when is it indicated?
Feliu J, González Barón M, Artal A, Ordóñez A, Cebreiros I, Martín G, Garrido P, Chacón I, Montero García JM. Feliu J, et al. Among authors: gonzalez baron m. Acta Oncol. 1991;30(5):587-91. doi: 10.3109/02841869109092423. Acta Oncol. 1991. PMID: 1654064
[Lung cancer in patients under 40 years of age: a different problem?].
Feliu J, González Barón M, Berrocal A, Barón Saura JM, Artal A, Garrido P, Ordóñez A, Jalón JI. Feliu J, et al. Among authors: baron saura jm, gonzalez baron m. Med Clin (Barc). 1991 Sep 28;97(10):373-6. Med Clin (Barc). 1991. PMID: 1660555 Spanish.
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
González Barón M, Chacón JI, García Girón C, Ordóñez Gallego A, García de Paredes ML, Feliu J, Zamora P, Herranz C, Garrido P, Artal A. González Barón M, et al. Acta Oncol. 1991;30(5):623-7. doi: 10.3109/02841869109092430. Acta Oncol. 1991. PMID: 1892680 Clinical Trial.
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
González Barón M, Artal A, Garrido P, García Girón C, Ordóñez A, Feliu J, Berrocal A, Barón JM. González Barón M, et al. Among authors: baron jm. Am J Clin Oncol. 1993 Aug;16(4):310-4. doi: 10.1097/00000421-199308000-00006. Am J Clin Oncol. 1993. PMID: 8392287 Clinical Trial.
Alternating chemotherapy in advanced gastric cancer. A phase II study.
Feliu J, Girón CG, González-Baron M, Berrocal A, Barón-Saura JM. Feliu J, et al. Among authors: baron saura jm, gonzalez baron m. Cancer Chemother Pharmacol. 1991;28(4):313-4. doi: 10.1007/BF00685542. Cancer Chemother Pharmacol. 1991. PMID: 1908751
225 results